sq-11725 has been researched along with Adenocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ben-Eliyahu, S; Domankevich, V; Levi, B; Naor, R; Rosenne, E; Shemer, S; Sominsky, L | 1 |
Abudarham, N; Ben-Eliyahu, S; Melamed, R; Rosenne, E; Schwartz, Y; Shakhar, K | 1 |
2 other study(ies) available for sq-11725 and Adenocarcinoma
Article | Year |
---|---|
Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Animals; Catecholamines; Cell Line, Tumor; Corticosterone; Cyclooxygenase Inhibitors; Cytotoxicity, Immunologic; Female; Indomethacin; Interleukin-6; Killer Cells, Natural; Lipopolysaccharides; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Nadolol; Prostaglandins; Rats; Rats, Inbred F344; Sex Characteristics; Tumor Necrosis Factor-alpha | 2009 |
Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Animals; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dinoprostone; Drug Therapy, Combination; Female; Indomethacin; Killer Cells, Natural; Laparotomy; Lung; Lung Neoplasms; Male; Mammary Neoplasms, Animal; Nadolol; Neoplasm Transplantation; Neoplastic Cells, Circulating; Postoperative Complications; Rats; Rats, Inbred F344 | 2005 |